Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough
about
Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinomaGlobal efforts in conquering lung cancer in China.MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer.Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review.
P2860
Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeted therapies for patient ...... : what's new and what's enough
@ast
Targeted therapies for patient ...... : what's new and what's enough
@en
Targeted therapies for patient ...... : what's new and what's enough
@nl
type
label
Targeted therapies for patient ...... : what's new and what's enough
@ast
Targeted therapies for patient ...... : what's new and what's enough
@en
Targeted therapies for patient ...... : what's new and what's enough
@nl
prefLabel
Targeted therapies for patient ...... : what's new and what's enough
@ast
Targeted therapies for patient ...... : what's new and what's enough
@en
Targeted therapies for patient ...... : what's new and what's enough
@nl
P2860
P921
P1476
Targeted therapies for patient ...... : what's new and what's enough
@en
P2093
Cai-Cun Zhou
P2860
P2888
P356
10.1186/S40880-015-0036-4
P407
P5008
P577
2015-07-01T00:00:00Z
2015-07-18T00:00:00Z
P5875
P6179
1019069000